Organovo Holdings, Inc., an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate key aspects of human disease, announced that its 2022 Annual Meeting of Stockholders that was scheduled to be held at 9:00AM on Wednesday, September 7, 2022 has been postponed to October 12, 2022 at 9:00AM, a date determined by the Company’s board of directors.
September 6, 2022
· 3 min read